Ultimately, it comes down to whether you want to take the risk of having Titanium Dioxide in your blood stream?

We have long been passionate about avoiding exposure to Titanium Dioxide & are proud that our products offer a safe alternative to Women everywhere. We strongly urge you to ditch your toxic, unsafe makeup & find a safer alternative.

5. Is EFSA banning titanium dioxide? 

Why does the exposure route matter, and what's the risk? 

We are committed to providing our customers with the highest quality products. Our Lithopone is manufactured using advanced technology and quality control processes to ensure consistent and reliable performance. We understand the importance of meeting your specific requirements, so we offer different grades of lithopone to meet the needs of various applications.

Très apprécié dans le travail des Icônes pour éclaircir, mais également pour les vernis, émaux, peintures, plastique et papier. A l'inverse, ne pas utiliser ce produit dans les applications cosmétiques, comme additif alimentaire ou comme additif médicamenteux.

Where It’s Hiding

CARACTÉRISTIQUES

According to CCM, many enterprises, which belong to the top exporting producers of TiO2 in China, will speed up their efforts to go public. Reasons are the strong rebound of the TiO2 market in China as well as the positive view on 2017.

In a 2016 study published in Scientifica (Cairo), Egyptian researchers examined the effects of titanium dioxide nanoparticles on the organs of mice by orally administering the food additive daily, for five days. The results showed that the exposure produced “mild to moderate changes in the cytoarchitecture of brain tissue in a time dependent manner.” Furthermore, “Comet assay revealed the apoptotic DNA fragmentation, while PCR-SSCP pattern and direct sequencing showed point mutation of Presenilin 1 gene at exon 5, gene linked to inherited forms of Alzheimer’s disease.” The researchers wrote: “From these findings, “the present study concluded that TiO2NPs is genotoxic and mutagenic to brain tissue which in turn might lead to Alzheimer’s disease incidence.”

≥30.0

The updated evaluation revises the outcome of EFSA’s previous assessment published in 2016, which highlighted the need for more research to fill data gaps.